These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 28257597)
1. International patterns and trends in ovarian cancer incidence, overall and by histologic subtype. Coburn SB; Bray F; Sherman ME; Trabert B Int J Cancer; 2017 Jun; 140(11):2451-2460. PubMed ID: 28257597 [TBL] [Abstract][Full Text] [Related]
2. International trends in ovarian cancer incidence from 1973 to 2012. Hao W; Zhang Y; Li Z; Zhang E; Gao S; Yin C; Yue W Arch Gynecol Obstet; 2021 Jun; 303(6):1589-1597. PubMed ID: 33616706 [TBL] [Abstract][Full Text] [Related]
3. International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973-2007. Trabert B; Chen J; Devesa SS; Bray F; McGlynn KA Andrology; 2015 Jan; 3(1):4-12. PubMed ID: 25331326 [TBL] [Abstract][Full Text] [Related]
4. Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012. Kim SI; Lim MC; Lim J; Won YJ; Seo SS; Kang S; Park SY J Gynecol Oncol; 2016 Jan; 27(1):e5. PubMed ID: 26463436 [TBL] [Abstract][Full Text] [Related]
5. Global Incidence of Ovarian Cancer According to Histologic Subtype: A Population-Based Cancer Registry Study. Wang M; Bi Y; Jin Y; Zheng ZJ JCO Glob Oncol; 2024 May; 10():e2300393. PubMed ID: 38754054 [TBL] [Abstract][Full Text] [Related]
6. Recent Trends in Ovarian Cancer Incidence and Relative Survival in the United States by Race/Ethnicity and Histologic Subtypes. Park HK; Ruterbusch JJ; Cote ML Cancer Epidemiol Biomarkers Prev; 2017 Oct; 26(10):1511-1518. PubMed ID: 28751475 [No Abstract] [Full Text] [Related]
7. Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort. Fortner RT; Ose J; Merritt MA; Schock H; Tjønneland A; Hansen L; Overvad K; Dossus L; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Benetou V; Lagiou P; Agnoli C; Mattiello A; Masala G; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; Onland-Moret NC; Peeters PH; Weiderpass E; Torhild Gram I; Duell EJ; Larrañaga N; Ardanaz E; Sánchez MJ; Chirlaque MD; Brändstedt J; Idahl A; Lundin E; Khaw KT; Wareham N; Travis RC; Rinaldi S; Romieu I; Gunter MJ; Riboli E; Kaaks R Int J Cancer; 2015 Sep; 137(5):1196-208. PubMed ID: 25656413 [TBL] [Abstract][Full Text] [Related]
8. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. Wentzensen N; Poole EM; Trabert B; White E; Arslan AA; Patel AV; Setiawan VW; Visvanathan K; Weiderpass E; Adami HO; Black A; Bernstein L; Brinton LA; Buring J; Butler LM; Chamosa S; Clendenen TV; Dossus L; Fortner R; Gapstur SM; Gaudet MM; Gram IT; Hartge P; Hoffman-Bolton J; Idahl A; Jones M; Kaaks R; Kirsh V; Koh WP; Lacey JV; Lee IM; Lundin E; Merritt MA; Onland-Moret NC; Peters U; Poynter JN; Rinaldi S; Robien K; Rohan T; Sandler DP; Schairer C; Schouten LJ; Sjöholm LK; Sieri S; Swerdlow A; Tjonneland A; Travis R; Trichopoulou A; van den Brandt PA; Wilkens L; Wolk A; Yang HP; Zeleniuch-Jacquotte A; Tworoger SS J Clin Oncol; 2016 Aug; 34(24):2888-98. PubMed ID: 27325851 [TBL] [Abstract][Full Text] [Related]
9. International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007. Petrick JL; Braunlin M; Laversanne M; Valery PC; Bray F; McGlynn KA Int J Cancer; 2016 Oct; 139(7):1534-45. PubMed ID: 27244487 [TBL] [Abstract][Full Text] [Related]
10. The influence of birth cohort and calendar period on global trends in ovarian cancer incidence. Cabasag CJ; Arnold M; Butler J; Inoue M; Trabert B; Webb PM; Bray F; Soerjomataram I Int J Cancer; 2020 Feb; 146(3):749-758. PubMed ID: 30968402 [TBL] [Abstract][Full Text] [Related]
11. Italian cancer figures, report 2012: Cancer in children and adolescents. ; ; Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445 [TBL] [Abstract][Full Text] [Related]
12. Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study. Machida H; Matsuo K; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kanauchi M; Nagase S; Enomoto T; Mikami M Gynecol Oncol; 2019 Jun; 153(3):589-596. PubMed ID: 30905436 [TBL] [Abstract][Full Text] [Related]
13. Global incidence comparisons and trends in ovarian germ cell tumors by geographic region in girls, adolescents and young women: 1988-2012. Hubbard AK; Poynter JN Gynecol Oncol; 2019 Sep; 154(3):608-615. PubMed ID: 31303255 [TBL] [Abstract][Full Text] [Related]
14. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use. Petitti DB; Porterfield D Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340 [TBL] [Abstract][Full Text] [Related]
15. Global distribution pattern of histological subtypes of epithelial ovarian cancer: a database analysis and systematic review. Sung PL; Chang YH; Chao KC; Chuang CM; Gynecol Oncol; 2014 May; 133(2):147-54. PubMed ID: 24556058 [TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States. Yang HP; Anderson WF; Rosenberg PS; Trabert B; Gierach GL; Wentzensen N; Cronin KA; Sherman ME J Clin Oncol; 2013 Jun; 31(17):2146-51. PubMed ID: 23650423 [TBL] [Abstract][Full Text] [Related]
17. Subtype Specific Nasopharyngeal Carcinoma Incidence and Survival Trends: Differences between Endemic and Non-Endemic Populations. Argirion I; Zarins KR; Suwanrungruang K; Pongnikorn D; Chitapanarux I; Sriplung H; Vatanasapt P; Rozek LS Asian Pac J Cancer Prev; 2020 Nov; 21(11):3291-3299. PubMed ID: 33247687 [TBL] [Abstract][Full Text] [Related]
18. Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000. Bray F; Loos AH; Tognazzo S; La Vecchia C Int J Cancer; 2005 Mar; 113(6):977-90. PubMed ID: 15505879 [TBL] [Abstract][Full Text] [Related]
19. Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas. Matsuo K; Matsuzaki S; Maeda M; Rau AR; Yoshihara K; Tamura R; Shimada M; Machida H; Mikami M; Klar M; Roman LD; Wright JD; Sood AK; Gershenson DM JAMA Netw Open; 2023 Jun; 6(6):e2318602. PubMed ID: 37326992 [TBL] [Abstract][Full Text] [Related]
20. Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries. Wong MC; Goggins WB; Wang HH; Fung FD; Leung C; Wong SY; Ng CF; Sung JJ Eur Urol; 2016 Nov; 70(5):862-874. PubMed ID: 27289567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]